NVO Stock Up 3% as UBS Upgrades Company Rating From Neutral to Buy
Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...
Zacks.com on MSN10h
LLY Falls Around 14% in 3 Months: How to Play the Stock
Eli Lilly and Company’s LLY shares declined 13.5% in the past three months. Though demand for its popular tirzepatide drugs, ...
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1421 ET – Biotech’s year ahead looks uncertain, but it could ...
thedailyupside23h
AI Wants to be the Future of Drug Discovery
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy
Transaction Expands Climb Bio’s Pipeline of B-cell Targeted Therapeutics to Address Immune-mediated Diseases New Program is a ...
The Bio Leg promises an improvement of life for amputees
At CES 2025, the Bio Leg robotic prosthetic knee is being hailed as a game-changer for amputees, offering an advancement over traditional passive prosthetics. Syakir Jasnee reports.